Page 2 - Mind Cure News Today

Vancouver-based Mind Cure Health Inc. launches a first-of-its-kind research program focused on female hypoactive sexual desire disorder.

/PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and...

MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors News provided by Share this article Share this article ATMA Was The First Private Sector Service Provider In Canada Conducting Legal Psychedelic-Assisted Therapy For A Palliative Care Patient Under The Approval Of Health Canadas Section 56(1) Exemption VANCOUVER, BC, April 8, 2021 /PRNewswire/ - Mind...

Here is a summary of the latest leadership changes within the cannabis industry. Papa & Barkley Announces Promotions, New Hires Cannabis wellness company Papa & Barkley has boosted its executive team with several promotions and new hires. Adam Grossman, who served as founder and CEO of... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

Earnings reports, M&A deal updates and a potential update regarding CannTrust Holdings Inc (NYSE: CTST) -- Heres what scheduled to take place this week in the cannabis industry. Organigram, Canopy Rivers Earnings As were entering the earnings season, we already see companies lining up... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

Psychedelics and mental health company The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded Atai in 2018, led the effort with Thiel Capital, the venture capital firm of tech billionaire Peter Thiel. Apeiron Investment Group and Woodline Partners LP also participated. Atai’s portfolio companies are researching 13 different psychedelic and non-psychedelic compounds for the treatment of a wide range of mental health disorde...

Psyched: Atai Raises $157M, Silo Wellness Goes Public, Mydecine Completes Export Of Magic Mushrooms Benzinga 3/8/2021 Psychedelics and mental health company Popular Searches The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded Atai in 2018, led the effort with Thiel Capital, the venture capital firm of tech billionaire Peter Thiel. Apeiron Investment Group and Woodline Partners LP also participated. Atai’s portfolio co...

The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. Digital therapeutics (DTx) are a form of patient care that are gaining momentum in the medical industry and the effects of the pandemic have only accelerated this growth.  In 2019, Insider Intelligence projected that the digital therapeutics industry would reach a mark...

The mental health wellness sector is poised to expand as mental health issues continue to disrupt the world. Every year, mental health disorders cost the global economy US$2.5 trillion. Companies that are helping society tackle this crisis have raised significant investment and gained widespread attention, especially in the wake of the COVID-19 pandemic. Significant investments in the mental health space In recent months, an increasing number of major investments have been made in the mental he...

Clever Leaves Appoints Hank Hague As CFO Clever Leaves Holdings Inc. (NASDAQ:CLVR) has tapped Hank Hague to oversee its financial department on the heels of being added to the Cannabis ETF (NYSE:THCX), which trades on the New York Stock Exchange. He led finances for several public and private companies within the pharmaceutical, biomedical, and cannabis industries during his career. Previously, Hague, who replaces Amit Pandey, served as CFO of Abacus Health Products, Inc. Kyle Detwiler, CEO of ...